Blood markers during menopause linked to later memory decline and Alzheimer's risk
UCSF researchers identified 16 blood molecules tied to brain aging that increase during the menopause transition in midlife. In older women, higher levels of these molecules correlated with poorer memory and thinking and greater Alzheimer's risk. The study, published in Nature Medicine, suggests menopause biology may help forecast dementia decades later, though it does not show causation.
The study focused on the menopause transition rather than a single date, since hormonal shifts can begin about ten years before the last period and continue afterward. Researchers enrolled 80 women in their 40s and 50s and used STRAW+10, which combines symptoms with hormone measurements, to locate each participant precisely within that transition.
A research blood panel measuring over 100 brain-related molecules revealed 16 that changed during menopause. Their levels tracked hormone concentrations more closely than chronological age. Inflammation-linked molecules tended to increase as estradiol fell, while a separate set associated with Alzheimer's-related processes increased alongside follicle-stimulating hormone. In older women, higher levels of these same markers were linked to poorer memory and thinking and greater Alzheimer's risk.
This research may affect midlife women and families by offering a future way to discuss brain health around menopause, when many already seek care for symptoms. If validated, blood markers could help clinicians identify women who might benefit from closer monitoring or risk-reduction conversations decades before dementia symptoms. It could also shape how menopause is viewed—not only reproductive change but a possible window into later cognitive health. However, because causation is not shown, any societal use should remain cautious.